Your session is about to expire
← Back to Search
Ketamine for Suicidal Thoughts in Children (Keta4SI Trial)
Keta4SI Trial Summary
This trial is testing whether ketamine can rapidly reduce depression and suicide severity in children, which could be a safer and more effective alternative to involuntary hospitalization.
Keta4SI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowKeta4SI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Keta4SI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I understand and agree to participate in the study.I am between 10 and 17 years old.I have stable blood pressure and no severe heart issues.I do not require intensive care to stabilize my condition.I haven't used benzodiazepines or ketamine in the last 3 months.I am currently experiencing hypomania, mania, or a mixed state.I am able to understand information, make decisions, and express my pain and satisfaction.I have had a stroke, seizures that aren't controlled, or high pressure in my brain.I have moderate to severe liver or kidney problems.
- Group 1: Intravenous ketamine
- Group 2: Intravenous midazolam
- Group 3: Intravenous saline
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are any geriatric patients partaking in this research endeavor?
"This clinical study requires participants to be aged between 10 and 17 years old."
How many individuals are capable of participating in this clinical trial?
"Indeed, clinicaltrials.gov reports that the trial is currently in need of participants. It was initially posted on June 1st 2022 and most recently updated on November 3rd 2022. The research requires 96 patients to be recruited from a single medical centre."
Is there a possibility that I may be enrolled in this experiment?
"This clinical trial is recruiting 96 minors between 10 and 17 years old exhibiting suicidal ideation. To be eligible, they must have responded affirmatively to either Passive or Active Ideation on the C-SSRS, given consent for admission into an inpatient facility via Capacity to Assent protocol and show no neurological anomalies as evaluated by a paediatric psychiatrist. Additionally, their vitals will need to fall within age appropriate norms."
Are there still enrollment opportunities for those interested in participating in this medical research?
"Affirmative. According to the information posted on clinicaltrials.gov, this medical investigation was initially listed on June 1st 2022 and recently modified in November 3rd of the same year. Consequently, 96 individuals are needed for enrollment at a single site."
In what instances is Ketamine Injectable Solution regularly prescribed?
"Ketamine Injectable Solution has been applied to manage seizures, epileptic episodes, amnesia and other therapeutic procedures."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger